One of the biggest growth areas in UK medicine, the medical cannabis market is blossoming, with imports tripling in 2023 and experts predicting exponential growth.
Medical cannabis, often referred to as cannabis-based medicinal products (CBPMs), relates to any products manufactured to a pharmaceutical grade that derives from cannabis.
The cannabis plant, containing over 120 cannabinoids, interact with the Endo-Cannabinoid system (ECS) that exists throughout the human central nervous system.
The most common cannabinoids found in the cannabis plant is CBD & THC.
In partnership with Curaleaf Education, extensive education resources can be found through their platform.
In November 2018, medical cannabis was made legal and available for private prescription in the UK.
Medical Cannabis prescriptions are currently issued by specialist doctors and clinics and can be considered for patients who have exhausted all traditional methods of treatment for range of indications.
Curaleaf Laboratories work with a number of specialist clinics and prescribers in the UK, who are providing their patients with medical cannabis treatment